Sunpeaks Ventures Inc. (OTC: SNPK) is one stock we are watching this week. On Monday, the penny stock rose 2.52% to finish the day at $1.22, taking its gains in the last three trading sessions to 32.61%. In the last one month, SNPK has gained 88.56%.
So what is driving this penny stock higher? A number of positive developments the company has announced in the last one month.
Sunpeaks, which is engaged in the distribution of hard-to-find and specialty drugs to the healthcare provider market, this month announced the signing of a sponsorship and marketing agreement with a major pro sports team for the marketing of Clotamin. The agreement was part of SNPK’s new marketing initiatives to launch Clotamin in 79 Walgreens locations in Oregon and southern Washington.
SNPK followed this up with another advertising and promotion agreement with another major sports team based in Arizona.
Sunpeaks also announced this month that its wholly-owned subsidiary, Healthcare Distribution Specialists LLC (HDS), signed a letter of intent with PharmaLife for placement of Clotamin with leading pharmacies in the Russian Federation.
All these developments have kept SNPK and its shares in news in the last few weeks.
Recent Comments